the mixed extract. In standardized extracts the stock formulation was prepared by tenfold dilution. Separate vial was used for allergen extract to reduce proteolysis degradation. All extracts were stored at 8 0 C . Therapeutic vaccine varied with each individual patient based on specific allergen identified during testing. Moist patients received a variety of aeroallergen combination. Table 1 . Patients characteristics at time of enrolled in the trial.
Determination of total serum IgE
ELISA was performed to estimate the total serum IgE level as a serological marker for treatment response monitoring. (20) Total serum IgE was determined by enzyme linked immunosorbant assay kit (Biomaghreb). Results were interpreted as allergy not probable if serum IgE was lower than 20 IU/ml, allergy is possible if IgE value is between 20 and 120 IU/ml and allergy is very probable if IgE is more than 120 IU/ml.
Classification of patients
In classifying the patients, two types of classification were adopted (3, 5) According to severity of symptoms. They were also sub classified into the following: mild group :A total 58 patients (31 active and 27 control); Moderate group: A total 81 patients (44 active and 37 control); and Severe group: A total 49 patients (27 active and 22 control) According to allergens. The patients were sub classified into the following : -Seasonal class: A total 78 patients (41 active and 37 control). -Perennial class: A total 110 patients (61 active and 49 control).
Family history of allergy
Because allergic diseases are familial diseases, some emphasis was laid on the families of patients to know the percentage of them that had allergic diathesis.
Systemic use of the black seed oil
The herb was given in the form of capsules, one capsule three times a day .Each capsule was about 0.6-0.8 gm of oil (which is about half of the dose that used in asthma in a previous study) (9) The control group received same shaped capsules but they contained ordinary food oil. The treatment was given for 6 weeks for both groups . The results were recorded on the patient's questionnaire each visit .The same routine physical examination and laboratory investigations as mentioned earlier were done and recorded in addition to the clinical evaluation which was done according to the following criteria:
Clinical assessment (symptom score)
During each visit, the patient was examined clinically for vital signs and questioned about the improvement in his day and night symptoms (Rhinorrhoea, nasal obstruction, paroxysm of sneezing, night snoring, daily physical activities, school attendance and affection of life quality). Symptom score was of 4 points scale (0-3) according to the classification of rhinitis symptoms as specified by: 0. No symptoms. 1. Mild symptoms: Symptoms not interfere with sleep, normal daily activities, (sports, leisure), no trouble of some symptoms, sneezing (not more than 3 in each attack or paroxysm), with mild runny nose (of no more than 1hour). (3, 5) 2. Moderate symptoms: Are of one or more items of the following: abnormal sleep, impairment of daily activities, (sports, and leisure), problems caused at work, at school with troublesome symptoms: longer attack > 1h. -<8 with uncomfortable stuffy, runny nose, sneering 4-10 sneeze each attack. (3, 5) 3. Severe symptoms: The same as moderate but more severe, more nasal blockage and sleep interference with severe distressing stuffy, runny nose for more than 8h. attack with sneeze more than 10 times each paroxysm. (3, 5) 
Tolerability to the exacerbating factors
Many precipitating factors such as aeroallergen exposure, cold exposure, infection (sinusitis), drugs ...etc. may precipitate the condition, so the response to the exacerbating factors were assessed in each visit by skin test.
Other associated allergic diseases
Other allergic diseases such as asthma, conjunctivitis and urticaria were also recorded in each visits.
Side effects
Side effects that were shown by the patients were recorded for both systemic and nasal uses. 
Statistical analysis

Results
For systemic trial, a total of 210 patients were included in the study. Of them 115 patients received the treatment [active group] and 95 patients were the controls. The patients were divided according to their disease severity, and each of the above groups was subdivided into active and control groups. As mentioned earlier, 188 patients completed the course of treatment in this study while 22 patients withdrawn from the study [ Table 1 ].
Age and sex frequency distribution
The eligible patients for analysis were subdivided into 3 groups as follow: Frequency distribution of the patients according to the duration of AR : Severe group had the longest duration of the diseases which was from 2.5 years-11 years, while mild group had the shortest duration range which was from 1 years-4 years. Classification of the patients according to allergen's type: One of the important classification of the allergic rhinitis depending on the type of exacerbating allergen into the seasonal and perennial type. Perennial type ( 110 patient, 58.5%) was more common than seasonal type (78 patient, 41.5%).
Monthly distribution of the patients
The monthly distribution of the patients indicated that 63.2% of cases were reported in March, April and May.
Exacerbating factors
The potent exacerbating factor in both groups was allergen exposure which account for 87.2% ,(89 patients) in active group and 74.2% (64 patients) in control group. The upper respiratory tract infection forms 38.2% ,(39 patients) in active group and 27.9% ,(24 patients) in control group. This is followed by temperature and humidity changes with cold exposure which was 25.4%,(26 patients) in active group and 25.5% ,(22 patients) in control group. Then smoke and irritants factor which was about 20.5% ,(21 patients) in active group and 16.2%,(14 patients) in control group .The last exacerbating factor that affect the disease in the studied patients was hormonal factor (i.e. pregnancy) which was 3.9% ,(4 patients) in active group and 2.3% ,(2 patients) in control group.
Family atopic diathesis
As it is clear from the history of patients as shown in Table 3 : atopic family diathesis with positive family history of allergy (in any form of allergy as asthma, eczema, and allergic rhinitis) was found in 41.3% (24 patients) of total mild group (13 control and 11 active) .This increased to 49.3% (40 patients) of total moderate group (19 control and 21active) .While the highest incidence was in severe allergic rhinitis group which was 63.2% (31 patients) (14 control and 17 active) .This means that the disease is generally more severe in patients of atopic diathesis or tendency.
Associated diseases
Conjunctivitis was the most common associated disease which accounted for 66.6% (68 patients) of total active group and 50% (43 patients) of total control group. Asthma was the second common associated disease. In active group it is accounted for 32.3% (33 patients) and in control group it is 30.2 (26 patients) while sinusitis which comes thirdly, accounted for 14.7% (15 patients) of active group and 19.7% (17 patients) of control group. The lowest associated disease was nasal polyposis which account for 3.9% (4 patients) of total active group and 2.3% (2 patients) of total control group.
Skin test results
In 33.5% of patients (63 patients) the test was positive to only one allergen and in 66.5% (125 patients) was positive to multiple allergen. Double allergen positive skin test results form 40.4% (76 patients), while triple allergen positive skin test results form 21.3% (40 patients) and lastly quadrant allergen positive skin test results form 4.8% (9 patients) of total 188 patients. For frequency distribution of the skin tests result according to allergens type, the highest incidence was HDM which accounted for 54.7% (103 patients), then Candida albicans 37.2% (70 patients). Animal dander account for 17% (32 patients), forms the lowest frequency.
IgE serum level
Serum IgE mean was 143 IU/ml in mild active and 168 IU/ml in mild control groups and were lower than those of the moderate groups (active,176 IU/ml; control, 188 IU/ml). This in turn was less than that of severe allergic rhinitis of both active (393 IU/ml) and control (361 IU/ml) groups. weeks treatment duration was highly significant (P=0.000) as compared to baseline for both mild and moderate active group. However, it was not significant in case of severe group.
Effects after 6 weeks systemic treatment 4.8.1 Symptomatic response: [
Serum IgE
The mean serum IgE level in mild active group decreased from 143 IU/ml at the baseline estimation to 91 after a 6 week treatment with N. sativa oil, while in mild control group, it decreased from 168 IU/ml to 131 IU/ml after a 6 week treatment with ordinary food oil. In moderate active group, it decreased from 176 IU/ml at the baseline estimation to 127 IU/ml after 6 weeks of treatment while for moderate control group also there was reduction in the IgE average level from 188 IU/ml to 152 IU/ml. In severe group, the IgE average level of severe active group decreased from 393 IU/ml to 354 IU/ml and the same thing occurred in control group which decreased from 361 IU/ml at the baseline estimation to 335 IU/ml at the end of the 6 week treatment. The reduction in serum IgE means level pre-and posttreatment was significant for both active and control groups, however, there was a significant differences between active and control groups [ 
Tolerability to the exacerbating factors
Improvement in tolerability of the exacerbating factors in total active group and total control group are shown in Table 6 . The response to allergen exposure has improved from 24.5% after 3 weeks (P=0.001) treatment to 37.5% at 6 weeks (P=0.000) treatment in the active group while in control group, the improvement was much less. The allergen exposure tolerability was significant during the treatment course (P=0.000), however, there was no significant difference between 3 and 6 weeks of treatment period. The response to temperature variation has also improved to about 7.8% at the end of 3 weeks (P=0.01) and to about 11.7% at the end of 6 weeks treatment in active group (P=0.001) .This is better than that of control group which was about 2.3 at the end of 3 weeks and increased to 4.6 (4 patients) at the end of 6 weeks . Another environmental factor that showed improvement www.intechopen.com was exposure to irritant gases which increased from 5.8% at the 3 week (P=0.03) treatment in active group to 9.8% at the end of 6 weeks (P=0.00 3) while in control group, a minor improvement occurred, which was from 2.31 after 3 weeks of treatment to 3.4% after 6 weeks of treatment. [ Table 4 ]. Table 4 . Tolerability to the exacerbating factors
Symptomatic response in associated allergic illnesses
The common associated allergic disease allergic rhinitis was allergic conjunctivitis which accounts for 66.6% (68 patients) and this was decreased to 21.5% (22 patients) at the 3 weeks (P=0.000) treatment then became 17.6% (18 patients) at the end of 6 weeks (P=0.000) treatment. While in control group, conjunctivitis affect 50% (43 patients) which showed some improvement after 3 weeks to 44.1% (38 patients) and decreased lastly to 39.5% (34 patients) at the end of 6 weeks treatment . The differences between active and control groups was significant for both 3 and 6 weeks course treatment (P=0.001). Table 5 . Asthma which was presented in 32.3%( 33 patients) of active group decreased to 21.5% (22 patients) after 3 weeks and then decreased to 18.6% (19 patients) at end of 6 weeks while in control group, 30.2% (26 patients) have asthma which showed improvement by decreasing in symptomatic patients to 26.7% (23 patients) at 3 weeks treatment, then decreasing to 24.4% (21 patients) at the end of 6 weeks treatment .however, the differences between active and control groups was not significant. Table 5 . The last associated disease was urticaria which showed some improvement : 9.8% (10 patients) were had symptoms at the beginning of the study and decreased to 6.8% (7 patients) at 3 weeks treatment which then decreased to 4.9% (5 patients) at the end of 6 weeks. While in control group, 8.1% (7 patients) have symptomatic urticaria decreased to 6.9% (6 patients) by 3 weeks and remained the same at the end of 6 weeks treatment. The demonstrated differences between active and control groups was not significant. 
Factors associated with poor response to systemic NS treatment in AR
The following factors seem to be associated with poor response to the systemic herb treatment [ Table. 6]: Multiple allergic diseases in the same patients, High IgE serum level, Gender (female), Perennial type more than seasonal one, Atopic diathesis, and Older age group.
Two weeks systemic oil treatment withdrawal effect
Two weeks systemic oil treatment with drawl effect is shown in Table 9 . In mild active group, from 96.7% that improved at 6 weeks treatment with black seed oil, 80.6% had recurrence of their symptoms which was significant (P=0.000) when compared with mild control group. The same pattern reported for moderate group in which, from 79.5% improved at the end of 6 weeks NS oil treatment, 72.7% had recurrence of their symptoms which was significant (P=0.009) as compared to control group. Severe group also showed no significant difference in recurrence rate.
Side effects
The side effect of systemic NS treatment was diarrhea (10.7%) and nasal dryness (0.9%).
Discussion
Allergic rhinitis represents a global health problem. It is a common disease worldwide by which at least 10-25% of the population is affected and its prevalence is increasing. Although allergic rhinitis is not usually a severe disease but it alters the social life of patients and affect school performance and work productivity, and so, the costs incurred by rhinitis are substantial. (2) New knowledge about the mechanisms underlying allergic inflammation of the air ways has resulted to better therapeutic strategies, like immunotherapy with engineered allergen. Even trails of laser surgery for treatment of AR by laser turbinectomy (Tiny biopsy specimens) with local destructive effect of laser energy on the glandular acini and on the surrounding cholinergic nerve fibers which leads to decrease nasal secretions. (21) . But still pharmacotherapy is the corner stone in the management of this illness, followed by immunotherapy (22) . All these therapeutic strategies have many side effects, some of them may prove dangerous or even lethal, and in addition, there is no curative therapy. One of the good substitutions is the use of herbal medicine and one of the ancient herbs that was used medically for many diseases was black seed extract (23) . This herb has been used for many diseases since no signs of toxicity or serious side effects were known in antiquity (24) . The role of herbal medicine in allergic rhinitis as an effective therapy has not been studied extensively (15, 16, 17, 25) and up to our knowledge, the use of topical N.S extract in treating A.R has not been studied yet. Although few studies have been conducted to illustrate the possibility of therapeutic effect of this herb on other allergic diseases like asthma (9, 2, 10, 11, 26) and allergic disease of the skin like urticaria (27) . Females were affected more than males. This may be due to the fact that most of our patients came from rural areas where females used to work long hours in the fields. Other studies showed no sex difference or slight male predominance (8) . About 71.7% of the patients were less than 25 years old which means that the onset mainly started during the childhood and adolescence. This goes in line with other studies (28) because allergy is a less common cause of rhinitis in elderly as compared with other forms of rhinitis like atrophic rhinitis (3) . The disease duration has a big correlation with the severity of the disease since the shortest duration was of mild type and the longest duration was of the severe allergic rhinitis group. This may be due to the fact that chronicity of the disease leads to more allergen exposure which, in turn, leads to more non specific hyper reactivity. Non specific nasal hyper reactivity is an important feature of chronic allergic rhinitis and it is defined as: increase nasal response to a normal stimuli resulting in sneezing, nasal congestion and/or secretion (3, 8) which lastly leads to more severe and chronic disease. Perennial type rhinitis were more than seasonal type. This may be due to more exposure since perennial allergens are present every were and at any time. The peak incidence occurred in spring season (from March to May with highest level in the April).This is due to the peak time for tree pollinosis in this area happens during these months which include exacerbation of seasonal type AR as well as perennial type . These results contradicts with the results of some other studies which were done in different geographical areas with different ecological environments (29) . The highest aggravating factor was allergen exposure simply because of the agricultural nature of the areas with more pollinosis and dampness, then upper respiratory tract infection followed by temperature changes then irritants and lastly hormonal factor. AR has mainly a bad course in the pregnant women since nasal obstruction may be aggravated by the pregnancy itself. (3, 5) Allergic disease mainly worsened during pregnancy. This is proved by the following physiological and epidemiological observations (5) :
The major physiologic factors are the direct and indirect effects of pregnancy associated hormones on nasal mucosa, that is estrogen cause nasal mucosal swelling, possibly through stimulation of local Ach production (5) .  Cyclic changes in human female nasal mucus are characterized by the formation of large ferns during ovulation followed by their disappearance premenstrual. (5)  Recent ultrastructrual and histochemical studies have revealed the increased activity of nasal mucous glands during pregnancy. A change similar to that is found in estrogens and progesterone contraceptive users. (5)  Pregnancy associated hormones may indirectly affect the nose through their circulatory effect. The increased circulating blood volume during pregnancy combined with nasal vascular smooth muscle relaxation for progesterone may contribute to the nasal mucosal congestion that occurs frequently during pregnancy. Epidemiologic observations showed that allergic rhinitis may occur in up to 20% of the population of women of child bearing age. (5) It has been noticed that patients with AR have a strong family history of allergic disease. This finding is in accordance with well documented fact in allergic disease. (30) (31) (32) the commonest associated illnesses was allergic conjunctivitis which may be as an entity associated with allergic rhinitis due to the same mechanism with the same allergen. Yet, it may be a reflex of histamine granules degranulation and it is considered one of allergic rhinitis co-morbidities. (3) Allergic asthma comes secondly in associated disease's frequency suggesting the concept that say "one air way, one disease". (33) Sinusitis is also one of the associated diseases and contributors to allergic rhinitis. (8, 34) The commonest allergen implicated is house dust mite (HDM) which may be the worldwide commonest cause of allergic rhinitis. (35) One example to the importance of (HDM) in respiratory allergens is that the incidence of the atopy in southern France is 30% but the prevalence of allergic asthma and rhinitis is greater in the low land compared to the ALPS. The reason for this difference in the prevalence of allergies (in the same population type and www.intechopen.com country) is considered to be the lower HDM population found above 1500 meters, and inhalant allergic patients are cleared an Alpine holiday despite the cold weather and exercise. (36) The severe symptoms patients had higher total serum IgE level then moderate symptomatic patient which in turn had higher level then mild symptomatic one .From this we can conclude that then increased in total serum IgE level correlates with the severity of the diseases. The mild and moderate active groups patients showed excellent improvement in clinical symptoms at the 3 and 6 week extract treatment which is statistically a highly significant as compared with control groups. The severe group also showed a good improvement in clinical symptoms for active group but was not statistically significant for 3 weeks treatment course. However, the treatment effect was statistically significant after 6 weeks course of therapy with black seed oil. The response to treatment in the severe group was lower than that in mild and moderate groups and this may be due to more associated co-morbidities especially asthma which may need higher doses of N.S. The improvement effect that is seen in different groups may be related to the antihistaminic activity of nigellon through membrane stabilizing action (37) , Anticholinergic activity by competitive property of the pinene (27) , Anti inflammatory effect of thymoqunone by effect on cyclo oxyginase & lipo oxyginase pathways) (29, 38) , immunomodulatory activity, and antioxidant activity. (23) The results also showed that the seasonal type has better responses than the perennial type which may be due to less nasal hyper reactivity appears because of less exposure to allergens (seasonal exposure only which don't continue very long ) and decrease in the level of pollination may occur through this 6 weeks treatment leads to decrease the triggering factor which result in the decrease of allergic reaction associated with the stabilizing action of N. sativa extract which leads to better response and an improved clinical state. Males patients show better treatment responses .This may be due to that males had less allergen exposure because of agricultural nature of this area which depends on females and hormonal changes in female through menstrual cycle changes affect the nasal mucosa and enhance disease exacerbations . IgE level estimation by ELISA showed no switching of any patients from probable allergic group to non allergic group with increased level in some patients even after taking N. sativa extract for 6 weeks. The average of each group patients showed some decline in their level than that of the baseline estimation but this reduction was significant for active and control groups. However, the reduction in serum IgE following 6 weeks of black seed treatment was higher as compared to control group. Salem (39) , reported that administration of nigellone to children and adults during the treatment of asthma, decreased the IgE level and eosinophil count. The reduction in total serum IgE level in control group may be a reflection of reduction in allergen exposure. The patients improved clinically without reduction in total serum IgE level to the level of non allergic individuals was due; firstly, measurement of total serum IgE level is not a measure of a specific IgE Ab which more specific predictor of atopy (28) . Secondly, since mast cellbound and non circulating IgE Ab are functionally important in initiating atopic reaction upon exposure to allergen. Measurement of the total quantity of IgE fixed to high affinity mast cell and basophile receptors (FC E R 1 ) might be more relevant to atopy than serum circulating IgE Ab but since there is no technique for making such measurement currently, there is only an estimation of skin mast cell-bound IgE by thresholds dilution skin testing with heterologous anti-IgE that show the tissue IgE level is much higher in atopic individuals than the normal population. (28) Improvement in tolerability to the exacerbating factors in active group, as it is compared with the control group after systemic treatment, may be due to the stabilizing effect of N.S on mast cell granules and antihistaminic properties of nigellone thymoquinone and subsequently prevent histamine release from macrophages, intracellular calcium release, protein kinase C activation and oxidative energy metabolism (40) . In a recent study, addition of NS seed to immunotherapy significantly increase the phagocytic and intracellular killing activities of PMNs in patients with AR (16) . Furthermore, NS inhibits the COX and 5-lipoxygenase pathways of arachidonic acid metabolism and decrease the synthesis of thromboxane and leukotrines (23, 41, 42) . Since leukotrines are a potent mediators that play a major role in allergic diseases including allergic rhinitis and histamine plays an important role in immediate hypersensitivity reactions, thus the above findings may explain the mechanism mediating the efficacy of NS in allergic diseases (2, 16) . Improvement in associated allergic symptoms of conjunctivitis, asthma, and urticaria in active groups was more than that of control groups revealed clearly the multiple anti allergic actions of N. sativa extract. This may be due to augmentation of PMN function induced by N. sativa seed oil (16, 39) , antihistaminic activity (40) , antioxidant activity (43) , inhibition of prostaglandin production (44) and antiiflamatory activity (45) . Factors associated with poor response to systemic NS treatment include: a) Multiple allergic disorders which may need more dose because the multiple allergic disease especially asthma are more complicated in mechanism than allergic rhinitis and the patients usually have bronchial hyper reactivity. The main antihistaminic action which act on AR occur at the lower doses of N. sativa. (37) While anti-inflammatory action to treat asthma needs higher doses for longer period. (27, 38) . b) High IgE level which reflects allergen exposure and correlate with worse atopic state. There are 2-4 fold variations in serum IgE levels with seasonal allergic rhinitis from spring or summer pollens (46) or ragweed pollen (47) . Peak IgE levels are usually reached about 4-6 weeks after the peak pollination period and then decline to a nadir just prior to the subsequent pollination season .Higher IgE level always correlates with a bad clinical features and a more resistance to treatment. c) Gender, Poor response in females may be because of, hormonal changes, more allergen exposure to females (agricultural areas depend mainly on female work). These are leading to many exacerbations which in turn leading to a more chronic symptoms with a more severe condition and a more resistance to treatment. d) Perennial type which is the year round exposure to allergen leads to more nasal hyperreactivity with a more severe cases due to non specific hyperactivity that leads to chronic disease with a more stubborn to treatment. f) High percentage of atopic family history: This makes the patients more vulnerable to allergic disorders at earlier ages than non atopic families patients. Earlier disease, mainly leads to more severe attacks in the future, because more nasal hyper reactivity, high IgE level and multiple allergic disease may happen. g) Older ages: They have more nasal hyper reactivity which is due to more allergen exposures and more attacks, in addition to more chronic disease which leads to non specific stimulation of nasal mucosa which in turn leads to more stubborn to treatment. Treatment cessation lead to high rate of recurrence rate. However, the rate of recurrence was more in mild group as compared to moderate and severe group. This variation was a reflection of the better response to treatment in mild as compared to other two groups. Thus the response to treatment with black seed oil was severity driven. The side effects of N. sativa extract used in allergic rhinitis was considered trivial as compared with conventional drugs used for allergic rhinitis like steroids or even antihistamines. One of these side effects of systemic N. sativa use was mild diarrhea which did not affect the administration of the herb. Excessive nasal dryness was much more in topical use; this may be due to more potent anti cholinergic effect in topical use than systemic use.
Conclusions
Systemic use of N. Sativa extract is effective in mild and moderate allergic rhinitis symptoms. Factors that may influence the response to systemic N.S treatment in allergic rhinitis include; multiple allergic diseases with high serum IgE level and atopic family diathesis, gender, perennial type, old age group patients. Side effects of N. Sativa extract use are trivial and easily controlled. Nigella sativa extract has proved to have a strong therapeutic effect in allergic rhinitis.
Recommendations
N.S extract oil has proved to be very effective in the treatment of AR so it is recommended as adjuvant therapy in patients treated with immunotherapy or conventional treatment. Conduction of long period treatment course clinical trial to elaborate the recurrence rate is warranted. To plan and conduct studies of longer periods and higher doses to clarify the therapeutic effect of this herb.
